Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
July 2nd, 2025: Rise in Ozempic Vision Loss Lawsuits Sparks Discussion on Broadening GLP-1 MDL Scope A growing wave of lawsuits is being filed against Novo Nordisk, alleging that its GLP-1 receptor agonist medicationsincluding Ozempic and Wegovycaused permanent vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION)
PC supplementation may improve cognitive performance and slow neurodegeneration by maintaining choline availability and membrane stability
We may recommend solutions such as digestive enzymes, the choline, or phentermine prescriptions
Turton MD, OShea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, et al
Tumours were allowed to develop for 56 weeks until mice showed signs of tumour burden, at which point mice were randomized and treated with a single i.p
